scienceAug 12, 202543:01pending
Acute Myeloid Leukemia — An Interview with Dr Jorge Cortes on Optimal Management of FLT3 and IDH1/2 Mutations
About this episode
Dr Jorge Cortes from Georgia Cancer Center at Augusta University discusses patient cases and summarizes current treatment approaches for FLT3- and IDH1/2-mutant acute myeloid leukemia.
CME information and select publications here.
Get every episode summarized
Each time Hematologic Oncology Update publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Hematologic Oncology Update
CD19 x CD3 BiTEs for Acute Lymphoblastic Leukemia — An Interview with Dr Bijal S...
Hematologic Oncology Update
Mar 13, 20261:03:21failed
Chronic Lymphocytic Leukemia — An Interview with Prof Constantine Tam on Key Pre...
Hematologic Oncology Update
Mar 11, 202647:10completed
Immune Thrombocytopenia — Microlearning Activity 2 with Dr Hanny Al-Samkari: ASH...
Hematologic Oncology Update
Mar 9, 202619:21failed
Immune Thrombocytopenia — Microlearning Activity 1 with Dr Hanny Al-Samkari: ASH...
Hematologic Oncology Update
Mar 4, 202624:25pending